Kuros reports publication of MagnetOs data demonstrating equivalence to autologous bone in spinal fusion
Schlieren (Zurich), Switzerland, December 6, 2018 – Kuros Biosciences (SIX: KURN) today announced the publication of data from a clinically-relevant preclinical model comparing MagnetOs with autologous bone in instrumented posterolateral spinal fusion in sheep. Utilizing multiple assessments for fusion, the study concluded that MagnetOs is a suitable alternative to autograft when used as a standalone graft.
The publication, which is entitled “Biphasic calcium phosphate with submicron surface topography in an Ovine model of instrumented posterolateral spinal fusion” was included in the December issue JOR Spine, an open-access Orthopaedic Research Society (ORS) journal.
- Study with sheep should further enhance competitive positioning of MagnetOs
- Sheep animal model is one of the most relevant preclinical model and believed to be
predictive of outcomes in humans
- 12-week fusion rate with MagnetOs granules & putty 92% & 83% versus autograft 75%